Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

AIDS Related Opportunistic Infections, Going but not Gone

  • Samuel, Rafik (Section of Infectious Diseases, Temple University Hospital) ;
  • Bettiker, Robert-L. (Section of Infectious Diseases, Temple University Hospital) ;
  • Suh, Byungse (Section of Infectious Diseases, Temple University Hospital)
  • Published : 2002.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

It is now more than two decades since the AIDS epidemic began with a cluster of Pneumocystis carinii pneumonia (PCP) in a community of homosexual men. Since then, many other infections have been characterized as opportunistic infections secondary to HIV infection. These include, but are not limited to, infections with Toxoplasma gondii, Cytomegalovirus (CMV), Mycobacterium avium complex (MAC), and Cryptococcus neoformans. Over the last two decades, there have been dramatic improvements in diagnosis, prevention and treatment of all these infections. As a result, in North America and Western Furope the rates of opportunistic infections secondary to AIDS have decreased substantially. We will review these common opportunistic infections below.

Keywords

References

  1. Anderson, K. P., Atlas, E., Ahern, M. J. and Weisbrot, I. M., Central nervous system toxoplasmosis in homosexual men. Am. J. Med., 75, 877-881 (1983) https://doi.org/10.1016/0002-9343(83)90420-5
  2. Antinori, A., Ammasasri, A., De Luca, A., Cingolani, A., Murri, R., Scoppettuolo, G., Fortini, M., Tartaglione, T., Larocca, L. M., Zannoni, G., Cattani, P., Grillo, R., Roselli, R., lacoangeli, M., Scerrati, M. and Ortona, L., Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 48 687-694 (1997) https://doi.org/10.1212/WNL.48.3.687
  3. Arribas, J. R., Clifford, D. B., Fichtenbaum, C.J., Commons, D. L., Powderly, W. G. and Storch, G. A., Level of Cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J. Infect. Dis., 172,527-531 (1995) https://doi.org/10.1093/infdis/172.2.527
  4. Arribas, J. R., Storch, G. A., Clifford, D. B., and Tselis, AC., Cytomegalovirus encephalitis. Ann.Intern. Med., 125, 577-587(1996) https://doi.org/10.7326/0003-4819-125-7-199610010-00008
  5. Baril, L., Jouan, M., Agher, R., Cambau, E., Caumes, E., Bricaire, F. and Katlama, C., Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and Cytomegalovirus disease in patients with AIDS. AIDS, 14,2593-2596 (2000) https://doi.org/10.1097/00002030-200011100-00023
  6. Beaugerie, L., Cywiner-Golenzer, C., Monfort, L., Girard, P. M., Carbonnel, F., Ngo, Y, Cosnes, J., Rozenbaum, W, Nicolas, J. C., Chatelet, F. P. and Gendre, J.P., Definition and ciagnosis of Cytomegalovirus colitis in patients infected by human immunodeficiency virus. J. Acquir. Immune. Defic. Syndr., 14,423-429 (1997) https://doi.org/10.1097/00042560-199704150-00005
  7. Bernett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., McGee, Z. A., Cate, T. R., Cobbs, C. G., Warner, J. F. and Alling, D.W., A comparison of amphotericin E alone and combined with flucytosine in treatment of cryptococcal meningitis. N. Engl. J. Med., 301, 126-131(1979) https://doi.org/10.1056/NEJM197907193010303
  8. Berson, C. A., Mycobacterium avium complex and other atypical mycobacterial infections. In Dolin R., Masur H., and Saag M. S. (ed), AIDS Therapy. Churchill Livingstone, Philadelphia. pp 375-390 (1999)
  9. Berson, C. A., Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin. Infect. Dis., 18(Suppl 3), S218-222 (1994) https://doi.org/10.1093/clinids/18.Supplement_3.S218
  10. Berson, C. A., Disseminated MAC infection: implications of recent clinical trials on prophylaxis and treatment. AIDS Clinical Review, 271-287 (1997-1998)
  11. Blanshard, C., Benhamou, Y., Dohin, E., Lernestedt, J. O., Gazzard. B. G. and Katlama, C., Treatment of AIDS-associated, gastrointestinal Cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J. Infect. Dis., 172,622-628 (1995) https://doi.org/10.1093/infdis/172.3.622
  12. Bozette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P., Fowderly, W G., He, W., Phillips, L., Craven, D., Van Der Horst, C. and Feinberg, J. A randomized trial of three antioneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 332, 693-699(1995) https://doi.org/10.1056/NEJM199503163321101
  13. Bozatte, S. A., Larsen, R. A., Chiu, J., Leal, M. A., Jacobsen, J., Fothman, P., Robinson, P., Gilbert, G., McCutchan, J. A. and Tilles, J., for the California Collaborative Treatment Group, A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med., 324, 580-584(1991) https://doi.org/10.1056/NEJM199102283240902
  14. Bustamante, E. A. and Levy, H. Sputum induction compared with bronchoalveolar lavage by Ballard catheter to diagnose Pneumocystis carinii pneumonia. Chest, 105, 816-822(1994) https://doi.org/10.1378/chest.105.3.816
  15. Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Perry, R. and Cooper, D.A., Low dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann. Intern. Med., 117, 106-111 (1992) https://doi.org/10.7326/0003-4819-117-2-106
  16. Certers for Disease Control task force on Kaposis sarcoma and opportunistic infections: epidemiologic aspects of the current outbreak of Kaposis sarcoma and opportunistic infections. N. Engl. J. Med., 306,248-252 (1982)
  17. Chaisson, R. E., Moore, R. D., Richman, D. D., Keruly, J., Creagh, T., and the zidovudine epidemiology study group, incidence and natural history of Mycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. Am. Rev. Respir. Dis., 146,285-289 (1992) https://doi.org/10.1164/ajrccm/146.2.285
  18. Chaisson, R. E., Benson, C. A., Dube, M. P., Heifets, L. B., Korvick, J. A., Elkin, S., Smith, T., Craft, J. C., Sattler, F. R., and the AIDS Clinical Trials Group Protocol 157 Study Team, c1arithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann. Intern. Med., 121,905-911 (1994) https://doi.org/10.7326/0003-4819-121-12-199412150-00001
  19. Chin, D. P., Reingold, A. L., Stone, E. N., Vittinghoff, E., Horsburgh, C. R., Simon, E. M., Yajko, D. M., Hadley, W. K., Ostroff, S. M. and Hopewell, P.C., The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patientsa prospective study. J. Infect. Dis., 170,578-584 (1994) https://doi.org/10.1093/infdis/170.3.578
  20. Chuck, S. L. and Sande, M. A., Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med., 321,794-799 (1989) https://doi.org/10.1056/NEJM198909213211205
  21. Collier, A. C., Meyers, J. D., Corey, L., Murphy, V. L., Roberts, P. L. and Handsfield, H. H., Cytomegalovirus infection in homosexual men: relationship to sexual practices, antibody to human immunodeficiency virus, and cell mediated immunity. Am. J. Med., 23, 593-601 (1987)
  22. Cox, G. M., and Perfect, J. R., AIDS-associated cryptococcal meningoencephalitis, UpToDate www.uptodate.com (2000)
  23. Currier, J. S., Williams, P. L., Koletar, S. L., Cohn, S. E., Murphy, R. L., Heald, A. E., Hafner, R., Basily, E L., Lederman, H. M., Knirsch, C., Benson, C. A., Valdez, H., Aberg, J. A., and McCutchan, J. A., for the AIDS Clinical Trials Group 362 Study Team, discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapyinduced increases in CD4+ cell count. Ann. Int. Med., 133, 493-503(2000) https://doi.org/10.7326/0003-4819-133-7-200010030-00008
  24. Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussblum, J., Clumeck, N., Morlat, P. and Chiu, J, Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann. Intern. Med., 116,33-43 (1992) https://doi.org/10.7326/0003-4819-116-1-33
  25. Davaro, R. E., and Himlan, P., Immune Restoration Disorders Following HAART. The AIDS Reader, 9,167-169 (1999)
  26. De Lorenzo, L. J., Huang, C. T., Maguire, G. P and Stover, D. E., Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest, 91, 323-327(1987) https://doi.org/10.1378/chest.91.3.323
  27. DeSimone, J., Pomerantz, R. J., and Babinchak, T. J., Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann. Intern. Med., 133,447-454 (2000) https://doi.org/10.7326/0003-4819-133-6-200009190-00013
  28. Detels, R., Munoz, A, McFarlane, G., Kingsley, L. A., Margolick, J. B., Giorgi, J., Schrager, L. K. and Phair, J. P, for the Multicenter AIDS Cohort Study investigators, effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA, 280, 1497-1503(1998) https://doi.org/10.1001/jama.280.17.1497
  29. Detels, R, Tarwater, P, Phair, J. P, Margolick, J., Riddler, S. A. and Munoz, A, for the Multicenter AIDS Cohort Study, effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. AIDS, 15,347-355 (2001) https://doi.org/10.1097/00002030-200102160-00008
  30. Diamond, R D., Cryptococcus neoformans, in Principles and Practice of Infectious Diseases, Mandell, G. L., Bennett, J. E., and Dolin, R, Churchill Livingstone, Philadelphia, pp 2707-2718 (2000)
  31. Dieterich, D. T., Kotler, D. P., Busch, D. F., Crumpacker C., Du Mond, C., Dearmand, D. and Buhles, W, Ganciclovir treatment of Cytomegalovirus colitis in AIDS: a randomized double-blind, placebo controlled multicenter study. J. Infect. Dis., 167,278-282 (1993) https://doi.org/10.1093/infdis/167.2.278
  32. Dismukes, W. E., Cloud, G., Gallis, H. A., Kerkering, T. M., Medoff, G., Craven, P. C., Kaplowitz, L. G., Fisher, J. F., Gregg, C. R. and Bowles, C. A. for the Mycosis Study Group, Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med., 317, 334-341 (1987) https://doi.org/10.1056/NEJM198708063170602
  33. Dohn, M. N., Weinberg, W. G., Torres, R. A., Follansbee, S. E., Caldwell, P. T., Scott, J. D., Gathe, J. C., Haghighat, D. P., Sampson, J. H., Spotkov, J., Derensinski, S. C., Meyer, R. D. and Lancaster, D. J., Oral atovaquone compared with intravenous pentamadine for Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med., 121,174-180 (1994) https://doi.org/10.1001/archinte.121.2.174
  34. El-Sadr, W. M., Burman, W. J., Grant, L. B., Matts, J. P., Hafner, R., Crane, L., Zeh, D., Gallagher, B., Mannheimer, S. B., Martinez, A., and Gordin, F., for the Terry Beirn Community Programs for Clinical Research on AIDS, discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. N. Engl. J. Med., 342,1085-1092 (2000) https://doi.org/10.1056/NEJM200004133421503
  35. Fitzpatrick, T. B., Johnson, R. A., Polano, M. K., Suurmond, D. and Wolff, K., Cryptococcosis, In Color Atlas and Synopsis of Clinical Dermatology. McGraw-Hill, New York pp. 326-327(1992)
  36. Follansbee, S. E., Busch, D. F., Wofsy, C. B., Coleman, D. L., Gullet, J., Auregemma, G. P., Ross, T., Hadley, W. K. and Drew, W. L. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann. Intern. Med., 96, 705-713 (1982) https://doi.org/10.7326/0003-4819-96-6-705
  37. Fox, J. D., Brink, N. S., Zuckerman, M. A., Neild, P., Gazzard, B. G., Tedder, R. S. and Miller, R. F., Detection of herpes virus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J. Infect. Dis., 172, 1087-1090 (1995) https://doi.org/10.1093/infdis/172.4.1087
  38. Freeman, W. R., Friedberg, D. N., Berry, C., Quiceno, J. I., Behette, M., Fullerton, S. C. and Munguia, D., Risk factors for development of rhegmatogenous retinal detachment in patients with Cytomegalovirus retinitis. Am. J. Ophthalmol., 116, 713-720 (1993) https://doi.org/10.1016/S0002-9394(14)73471-3
  39. French, M. A. H., Antiretroviral therapy immune restoration disease in HIV-infected patients on HAART. The AIDS Reader, 9, 548-562 (1999)
  40. Furrer, H., Oppravil, M., Bernasconi, E., Telenti, A., and Egger, M., Stopping primary prophylaxis in HIV-1 infected patients at high risk of Toxoplasma encephalitis. Swiss HIV Cohort Study. Lancet, 355, 2217-2218 (2000) https://doi.org/10.1016/S0140-6736(00)02407-7
  41. Gagnon, S., Boota, A. M., Fischl, M. A., Baier, H., Kirskey, O. W. and La Voie, L., Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double blind placebo controlled trial. N. Engl. J. Med., 323,1444-1450 (1990) https://doi.org/10.1056/NEJM199011223232103
  42. Gallant, J. E., Moore, R, Richman, D. D., Keruly, J., Chaisson, R. E., and the zidovudine Epidemiology study group, Incidence and natural history of Cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis., 166, 1223-1227(1992) https://doi.org/10.1093/infdis/166.6.1223
  43. Garofano S., Cryptococcal pulmonary infections in AIDS, UpToDate www.uptodate.com (1998)
  44. Girard, P. M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P, Gaudebout, C., Certain, A., Bove, F. and Bowet, E., Dapsone-pyrimethamine. compared with aerosolized pentamadine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. N. Engl. J. Med., 328, 1514-1520 (1993) https://doi.org/10.1056/NEJM199305273282102
  45. Gold, E. and Nankervis, G. A., Cytomegalovirus. In Evans AS(ed): Viral infections of humans: Epidemiology and Control, ed 2. New York, Plenum Press, pp 167 (1982)
  46. Goodgame, R. W., Gastrointestinal Cytomegalovirus disease. Ann. Intern. Med., 119,924-935 (1993) https://doi.org/10.7326/0003-4819-119-9-199311010-00010
  47. Gottlieb, M. S., Schroff, R., and Schanker, H. M., Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med., 305, 1425-1431 (1981) https://doi.org/10.1056/NEJM198112103052401
  48. Grabill, J. R, Sobel, J., Saag, M., van der Horst, C., Powderly, W., Cloud, G., Riser, L., Hamill, R., Dismukes, W., and the NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups, diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin. Infect. Dis., 30, 47-54 (2000) https://doi.org/10.1086/313603
  49. Grinsztejn, B., Fandinho, F. C. O., Veloso, V. G., Joao, E. C., Lourenco, M. C. S., Nogueira, S. A., Fonseca, L. S. and Werneck-Barroso, E., Mycobacteremia in patients with the acquired immunodeficiency syndrome. Arch. Intern. Med., 157, 2359-2363 (1997) https://doi.org/10.1001/archinte.157.20.2359
  50. Gruden, J. F., Huang, L., Turner, J., Webb, W. R., Merrifield, C., Stansell, J. D., Gamsu, G., and Hopewell, P. C., High resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal equivocal, or nonspecific radiographic findings. Am. J. Roengenol., 169,967-975 (1997) https://doi.org/10.2214/ajr.169.4.9308446
  51. Hauser, W. E., Luft, B. J., Conley, F. K. and Remington, J. S., Central nervous system toxoplasmosis in homosexual and heterosexual adults. N. Engl. J. Med., 307, 498-499 (1982)
  52. Havik, J. A., Horsburgh, C. R., Mechock, B., Williams, P. P., Fann, S. A, and Thompson, S. E., Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends. J. Infect. Dis., 165,577-580 (1992)
  53. Havlir, D. V., Dube, M. P., Sattler, F. R., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Lavelle, J. P., White, A. C., Witt, M. D., Bozzette, S. A and McCutchan, J.A., for the California Collaborative Treatment Group, prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N. Engl. J. Med., 335, 392-398 (1996) https://doi.org/10.1056/NEJM199608083350604
  54. Havlir, D. and Ellner, J., Mycobacterium avium Complex., In Mandell, Bennett, and Dolin (ed), Principles and Practices of Infectious Diseases, Churchill Livingston, Philadelphia, pp.2316-2625 (2000)
  55. Heweg-Larsen, J., Tsolaki, A. G., Miller, R. F., Lundgren, B. and Wakefield, A.E., Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. Q.J.M., 91, 813-820(1998) https://doi.org/10.1093/qjmed/91.12.813
  56. Holland, G. N., Tufail, A. and Jordan, M.C., Cytomegalovirus diseases. In Pepose J. S., Holland G. N., and Wilhelmus K. R. (eds): Ocular infection and immunity St. Louis, CV Mosby Company p. 1088 (1996)
  57. Horsburqh, C. R., Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med., 324, 1332-1338 (1991) https://doi.org/10.1056/NEJM199105093241906
  58. Horsburqh, C. R., Chin, D. P., Yajko, D. M., Hopewell, P. C., Nassos, P. S., Elkin, E. P., Hadley, W. K., Stone, E. N., Simon E. M., Gonzalez, P., Ostroff, S. and Reingold, A. L., Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency Virus infection. J. Infect. Dis., 170, 362-367 (1994) https://doi.org/10.1093/infdis/170.2.362
  59. Horsburqh, C.R., Epidemiology of Mycobacterium avium Complex Disease. In John Phair & Lowell Young (ed) Clinical Challenges of Mycobacterium avium. Am. J. Med., 102(5C) pp 11-15, (1997) https://doi.org/10.1016/S0002-9343(97)00038-7
  60. Huqhes, W. T. Pneumocystis carinii pneumonia. N. Engl. J. Med., 297, 1381-1383 (1977) https://doi.org/10.1056/NEJM197712222972505
  61. Hughes, W., Lwoung, G., Kramer, F., Bozette, S. A., Safrin, S., Frame, P., Clumeck, N., Masur, H., Lancaster, D., Chan, C., Lavelle, J., Rosenstock, J., Falloon, J., Feinberg ,J., LaFon, S., Rogers, M. and Sattler, F., Comparison of atovaquone with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med., 328,1521-1527 (1993) https://doi.org/10.1056/NEJM199305273282103
  62. Jacobson, J. M., Hafner, R., Remington, J., Farthing, C., Holden-Wiltse, J., Bosler, E. M., Harris, C., Jayaweera, D. J., Roque, C. and Luft, B. J., Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. AIDS, 15, 583-589 (2001) https://doi.org/10.1097/00002030-200103300-00007
  63. Jacobson, M. A Cytomegalovirus. In Dolin R, Masur H, and Saag MS (ed), AIDS Therapy. Churchill Livingstone, Philadelphia. pp 456-471 (1999)
  64. Kales, C. P., Murren, J. R., Torres, R. A and Crocco, J. A, Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. Arch. Intern. Med., 147, 1413-1417 (1987) https://doi.org/10.1001/archinte.147.8.1413
  65. Katlama, C., De Wit, S., Odoherty, E., Van Glabeke, M. and Clumeck, N., Pyrimethamine-clindamycin vs pyrimethamin-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin. Infect. Dis., 22, 268-275(1996) https://doi.org/10.1093/clinids/22.2.268
  66. Kemper, C. A., Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen: rifampin, ethambutol, clofazimine, and ciprofloxacin. Ann. Intern. Med., 116, 466-472 (1992) https://doi.org/10.7326/0003-4819-116-6-466
  67. Kilby, J. M., Marques, M. B., Jaye, D. L., Tabereaux, P. B., Reddy, V. B. and Waites K. B., The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am. J. Med., 104, 123-128 (1998) https://doi.org/10.1016/S0002-9343(97)00353-7
  68. Koletar, S. L., Treatment of Mycobacterium avium in human immunodeficiency virus-infected individuals, In Clinical Challenges of Mycobacterium avium. Am. J. Med., 102(5C),pp.16-21 (1997)
  69. Korvick, J. A., Mycobacterium avium Complex. In Yu, Merigan, and Barriere, (eds) Antimicrobial Therapy and Vaccines, Williams & Wilkins, Baltimore, pp. 497-508 (1999)
  70. Kravcik, S., Hawley-Foss, N., Victor, G., Angel, J. B., Garber, G. E., Page, S., Denomne, N., OReilly, L. and Cameron, D. W., Causes of death of HIV infected persons in Ottawa, Ontario, 1984-1995. Arch. Intern. Med., 157, 2069-2073 (1997) https://doi.org/10.1001/archinte.157.18.2069
  71. Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, L. and Jaffe, H. S., Intravenous cidofovir for peripheral Cytomegalovirus retinitis in patients with AIDS a randomized, controlled trial. Arm. Intern. Med., 126, 257-263 (1997) https://doi.org/10.7326/0003-4819-126-4-199702150-00001
  72. Ledergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., Kaufmann, D., Sudre, P., Francioli, P., Telenti, A., AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. The Swiss HIV cohort study. JAMA, 282, 2220-2226 (1999) https://doi.org/10.1001/jama.282.23.2220
  73. Levy, R. M., Mills, C. M., Posin, J. P., Moore, S. G., Rosenblum, M. L. and Bredesen, D. E., The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J. Acquir. Immune. Defic. Syndr., 3,461-471 (1990)
  74. Lorberboym, M., Wallach, F., Estok, L., Mosesson, R. E., Sacher, M., Kim, C. K. and Machac, J., Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and non-malignant lesions in AIDS patients. J Nucl. Med., 39, 1366-1369 (1998)
  75. Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D. $3^{rd}$, Uttamchandani, R, Fuhrer, J. and Jacobson, J., Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N. Engl. J. Med., 329, 995-1000 (1993) https://doi.org/10.1056/NEJM199309303291403
  76. Lunseth, J. H, Kirmse, T. W., Prezyna, A. P. and Gerth, R. E., Interstitial plasma cell pneumonia. J. Pediatr., 46, 137-145 (1955) https://doi.org/10.1016/S0022-3476(55)80202-8
  77. Masur, H., Michelis, M. A. and Greene, J.B., An outbreak of community-acquired Pneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction. N. Engl. J. Med., 305,1431-1438 (1981) https://doi.org/10.1056/NEJM198112103052402
  78. McCutchan, J. A., Cytomegalovirus infections of the nervous system in patients with AIDS. Clin. Infect. Dis., 20, 747-754(1995) https://doi.org/10.1093/clinids/20.4.747
  79. McNeil, J. I. and Kan, V. L., Decline in the incidence of cryptococcosis among HIV-infected patients. J Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9, 206-208 (1995)
  80. Montaner, J. S. G., Lawson, L. M., Levitt, N., Belzberg, A., Schechter, M. T and Ruedy, J., Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann. lntern. Med., 113, 14-20(1990) https://doi.org/10.7326/0003-4819-113-1-14
  81. Montoya, J. G., Remington, J. S. Toxoplasma gondii. In: Principles and practice of infectious diseases, $5^{th}$ ed. Mandell G. L., Bennett J. E. and Dolin R. (Eds). Churchill Livingston, Philadelphia. p. 2858 (2000)
  82. Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., Kuppermann, B. D. and the ganciclovir implant study group. Treatment of Cytomegalovirus retinitis with a sustained release ganciclovir implant. N. Engl. J Med., 337, 83-90(1997) https://doi.org/10.1056/NEJM199707103370203
  83. National Institutes of Health-University of California expert panel for corticosteroids as adjunctive therapy for Pneumocystis pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med., 323,1500-1504 (1990) https://doi.org/10.1056/NEJM199011223232131
  84. Nightingale, S. D., Byrd, L. T., Southern, P.M., Jockusch, J. D., Cal, S. X. and Wynne, B. A, Incidence of Mycobacterium avium-intracellulare complex infections bacteremia in human immunodeficiency virus-positive patients. J. Infect. Dis., 165, 1082-1085 (1992) https://doi.org/10.1093/infdis/165.6.1082
  85. Palella, F J., Delaney, K. M., Moorman, A C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D., and the HIV Outpatient Study Investigators, declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med., 338,853-860 (1998) https://doi.org/10.1056/NEJM199803263381301
  86. Peacock, K., Lewis L. and Lavoie S., Erosive mediastinal lymphadenitis associated with M. avium infection in a pediatric acquired immunodeficiency syndrome patient. Ped. Infectious Disease J., 19, 576-578 (2000) https://doi.org/10.1097/00006454-200006000-00020
  87. Phair, J., Munoz, A., Detels, R., Kaslow, R., Rinaldo, C. and Saah, A., The risk of Pneumocystis carinii pneumonia among men infected with the human immunodeficiency virus type I. Multicenter AIDS cohort study group. N. Engl. J. Med., 322, 161-165 (1990) https://doi.org/10.1056/NEJM199001183220304
  88. Pierce, M., Crampton, S., Henry, D., Heifets, L., LaMarca, A., Montecalvo, M., Wormser, G., Jablonowski, H., Jemsek, J., Cynamon, M., Yangco, B., Notario, G., and Craft, J. C., A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N. Engl. J. Med., 335, 384-391 (1996) https://doi.org/10.1056/NEJM199608083350603
  89. Pifer, L. L., Hughes, W. T., Stango, S. and Woods, D., Pneumocystis carinii infection: evidence of high prevalence in normal and immunosuppressed children. Pediatrics, 61,35-41 (1978)
  90. Porter, S. B. and Sande, M.A., Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N. Engl. J. Med., 327,1643-1648 (1992) https://doi.org/10.1056/NEJM199212033272306
  91. Powderly, W. G., Cryptococcosis. In Dolin R., Masur H., and Saag M. S. (ed), AIDS Therapy. Churchill Livingstone, Philadelphia. pp 400-411 (1999)
  92. Rabaud, C., May, T., Amiel, C., Katlama, C., Leport, C., Ambroise-Thons, P. and Canton, P., Extracerebral toxoplasmosis in patients infected with HIV. A French national survey. Medicine, 73, 306-314 (1994) https://doi.org/10.1097/00005792-199411000-00004
  93. Ribera, E., Fernandez-Sola, A., Juste, C., Rovira, A., Romero, F. J., Armadans-Gil, L., Ruiz, I., Ocana, I. and Pahissa, A., Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin. Infect. Dis., 29, 1461-1466 (1999) https://doi.org/10.1086/313515
  94. Rigsby, M. O., and Curtis, A. M., Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus. Chest, 106, 913-919 (1994)
  95. Rozenbaum, R. and Goncalves, A. J. R, Clinical epidemiological study of 171 cases of cryptococcosis. Clin. Infect. Dis., 18, 369-380 (1994) https://doi.org/10.1093/clinids/18.3.369
  96. Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, M. H., Sharkey, P. K., Thompson, S. E., Sugar, A.M., Tuazon, C. U., Fisher, J. F., Hyslop, N., Jacobson, J. M., Hafner, R., Dismukes, W. E., and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group, comparison of amphotericin B with fluconazole in the treatment of acute ADS-associated cryptococcal meningitis. N. Engl. J Med. 326, 83-89 (1992) https://doi.org/10.1056/NEJM199201093260202
  97. Saag, M. S., Graybill, R. J., Larsen, R A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D. and Dismukes, W. E., for the Mycoses Study Group Cryptococcal Subproject, practice guidelines for the management of crypyococcal disease. Clin. Infect. Dis., 30, 710-718 (2000) https://doi.org/10.1086/313757
  98. Sabin, A. B., Toxoplasmic encephalitis in children. JAMA, 116, 801-807. (1941) https://doi.org/10.1001/jama.1941.02820090001001
  99. Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Selnes, O. A, Miller, E. N., Becker, J. T., Cohen, B. and Mcarthur, J. C. HIV-associated neurologic disease incidence changes: Multicenter AIDS cohort study. 1990-1998. Neurology, 56, 257-260 (2001) https://doi.org/10.1212/WNL.56.2.257
  100. Safrin, S., Finkelstein, D. M., Feinberg, J., Frame, P., Simpson, G., Wu, A., Cheung, T., Soeiro, R., Hojczyk, P. and Black, J. R. Comparison of three regimens for the treatment of mild to moderate Pneumocystis carinii Pneumonia in patients with AIDS A double blind, randomized trial of oral trimethoprim sulfamethoxazole, dapsone-trimethoprim and c1indamycin-prmaquine. Ann. Intern. Med., 124, 792-802 (1996) https://doi.org/10.7326/0003-4819-124-9-199605010-00003
  101. Selk R. M., Chu, S. Y. and Ward, J. W., Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann. Intern. Med., 123,933-936 (1995) https://doi.org/10.7326/0003-4819-123-12-199512150-00006
  102. Sepkowitz, K. A., Telzak, E. E., Gold, J. W. M., Bernard, E. M., Blum, S., Carrow, M., Dickmeyer, M. and Armstrong, D., Pneumothorax in AIDS. Ann. Intern. Med., 114, 455-459(1991) https://doi.org/10.7326/0003-4819-114-6-455
  103. Shafran, S. T., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, J., Rachlis, A R., Lalonde, R. G., Fanning, M. M., and Tsoukas, C., for the Canadian HIV Trials Network Protocol 010 Study Group, A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N. Engl. J. Med., 335, 377-383 (1996) https://doi.org/10.1056/NEJM199608083350602
  104. Spector, S. A., McKinley, G. F., Lalezari, J. P., Samo, T., Andruczk, R., Follansbee, S., Spartl, P. D., Havlir, D. V., Simpson, G., Buhles, W., Wong, R. and Stempien, M. J., For the Roche cooperative oral ganciclovir study group. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N. Engl. J. Med., 334,1491-1497 (1996) https://doi.org/10.1056/NEJM199606063342302
  105. So, Y. T. and Olney, R. K., Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol., 35, 53-58 (1994) https://doi.org/10.1002/ana.410350109
  106. Stansell, J. D., Osmond, D. H., Charlebois, E., Lavange, L., Wallace, J. M., Alexander, B. V., Glassroth, J., Kvale, P. A., Rosen, M. J., Reichman, L. B., Turner, J. R. and Hopewell, P. C. Predictors of Pneumocystis carinii pneumonia in HIV infected persons. Am. J Respir. Crit. Care. Med., 155, 60-66(1997) https://doi.org/10.1164/ajrccm.155.1.9001290
  107. Stover, D. E. and Meduri, G. U., Pulmonary function tests. Clin. Chest. Med., 9, 473-479 (1988)
  108. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcomes in patients with AIDS and CMV retinitis treated with either foscarnet or ganciclovir. J. Infect. Dis., 176, 50-58 (1997) https://doi.org/10.1086/514039
  109. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed Cytomegalovirus retinitis in patients with AIDS. Arch. Ophthalmol., 114, 23-33 (1996) https://doi.org/10.1001/archopht.1996.01100130021004
  110. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann. Intern. Med., 126, 264-274(1997) https://doi.org/10.7326/0003-4819-126-4-199702150-00002
  111. Tietjen. P A., Clinical presentation and diagnosis of Pneumocystis carinii infection in HIV-infected patients. UpToDate www.uptodate.com (2001)
  112. Toma, E., Fournier, S., Dumont, M., Bolduc, P. and Deschamps, H., Clindamycin/primaquine versus trimethoprim sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: A Randomized, double blind Pilot trial. Clin. lnfect. Dis., 17, 178-184 (1993) https://doi.org/10.1093/clinids/17.2.178
  113. Toma, E., Thorne, A., Singer, J., Raboud, J., Lemieux, C., Trottier, S., Bergeron, M. G., Tsoukas, C., Falutz, J., Lalonde, R., Gaundreau, C., Therrien, R., and the CTN-PCP Study group. Clindamycin with primaquine vs trimethoprim sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: A multicenter, double blind randomized trial (CTN 004). Clin. Infect. Dis., 27, 524-530 (1998) https://doi.org/10.1086/514696
  114. Torres, J., Goldman, M., Wheat, L. J., Tang, X., Bartlett, M. S., Smith, J. W., Allen, S. D. and Lee, C. H., Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus infected patients with polymerase chain reaction: a blinded comparison to standard methods. Clin. Infect. Dis., 30, 141-145(2000) https://doi.org/10.1086/313584
  115. Torres, R A., Weinberg, W., Stansell, J., Leoung, G., Kovacs, J., Rogers, M. and Scott, J., Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group. Clin. Infect. Dis., 24, 422-429 (1997) https://doi.org/10.1093/clinids/24.3.422
  116. Uberti-Foppa, C., Lillo, F., Terreni, M. R., Puglisi, A., Guffanti, M., Gianotti, N. and Lazzarin, A., Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus cultures from BAL fluid and correlation with lung disease. Chest, 113, 919-923(1998) https://doi.org/10.1378/chest.113.4.919
  117. United States Public Health Service/Infectious Diseases Society of America Prevention of Opportunistic Infections Working Group, 'Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (Draft),' available at www.hivatis.com. July 2001
  118. Van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moscovitz, B. L., Powderly, W. G., and Dismukes, W. E., for the Mycoses Study Group and AIDS Clinical Trials Group, treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N. Engl. J. Med., 337,15-21 (1997) https://doi.org/10.1056/NEJM199707033370103
  119. Vilaseca, J., Arnau, J.M., Bacardi, R, Mieras, C., Serrano, A., Navarro, C. Kaposis sarcoma and Toxoplasma gondii brain abscess in a Spanish homosexual. Lancet, 1,572 (1982)
  120. Von Reyn, C. F., Barber, T. W., Arbeit, R. D., Sox, C. H., OConnor,G. T., Brindle, R. J., Gilks, C. F., Ranki, A., Hakkarainen, K., Bartholomew, C., Edwards, J., Tosteson, A. N. A. and Magnusson, M., Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J. Infect. Dis., 168, 1553-1558 (1993) https://doi.org/10.1093/infdis/168.6.1553
  121. Whitcup, S. M., Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA, 283, 653-657 (2000) https://doi.org/10.1001/jama.283.5.653
  122. Whitley, R. J., Jacobson, M. A., Friedberg, D. N., Holland, G. N., Jabs, D. A., Dietrich, D. T., Hardy, W. D., Polis, M. A., Deutsch, T. A., Feinberg, J., Spector, S. A., Walmsley, S., Drew, W. L., Powderly, W. G., Griffiths, P. D., Benson, C. A., Kessler, H. A. for the international AIDS society-USA. Guidelines for the treatment of Cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Recommendations of an international panel. Arch. Intern. Med., 158, 957-969 (1998)䈈骈 ⨀㨯䬄촒က䀚⨀ሀ老 https://doi.org/10.1001/archinte.158.9.957
  123. Woods, M. L., MacGinley, R., Eisen, D. P. and Allworth, A. M., HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS, 12, 1491-1494(1998) https://doi.org/10.1097/00002030-199812000-00011
  124. Zakowski, P., Fligiel, S., Berlin, O. G. W. and Johnson, B.L., Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA, 248, 2980-2982 (1982) https://doi.org/10.1001/jama.248.22.2980
  125. Zaman, M. K. and White, D. A, Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia: diagnostic and prognostic significance. Am. Rev. Respir. Dis., 137, 796-800(1988) https://doi.org/10.1164/ajrccm/137.4.796
  126. Zaman, M. K., Wooten, O. J., Suprahmanya, B., Ankobiah, W., Finch, P. J., Kamholz, S. L. Rapid non-invasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann. Intern. Med., 109, 7-10 (1988) https://doi.org/10.7326/0003-4819-109-1-7
  127. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. and Rahal, J. J., Cryptococcal disease in patients with acquired immunodeficiency syndrome. Ann. Intern. Med., 104, 234-240(1986) https://doi.org/10.7326/0003-4819-104-2-234